26 Nov 2015 10:24
(ShareCast News) - A clinical study part-funded by EKF Diagnostics has provided encouraging data about its soluble biomarker in predicting the progression of diabetic kidney disease, which could lead to recruitment of more suitable patients for further trials. The study, which was co-authored by EKF
Read more